Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,

Slides:

Advertisements

Similar presentations

Adverse pregnancy and neo-natal outcomes after assisted reproductive treatment in patients with pelvic endometriosis: a case–control study Marianne Jacques,

Advertisements

Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Sesh Kamal Sunkara, Jyotsna Pundir,

Cancer and fertility: strategies to preserve fertility

Kay Neumann, Georg Griesinger Reproductive BioMedicine Online

Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C

Fresh and cryopreserved ovary transplantation and resting follicle recruitment Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.

FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles Scott J. Morin, Ashley W. Tiegs, Jason M.

Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis Mireia González-Comadran, Montserrat Durán,

Norbert Gleicher, Andrea Weghofer, David H. Barad

Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague–Dawley rats Pınar Özcan, Cem Fıçıcıoğlu, Özge Kızılkale.

External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients Scott M.

Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction Antonio La Marca, Giovanni D’Ippolito

N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A

Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol Qi Yao, Yuanjiao Liang, Yong.

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis Annelies Overbeek, Frank J. Broekmans, Wouter.

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors Nikolaos P. Polyzos, Dominic Stoop, Christophe.

A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C

In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation

L. L. van Loendersloot, M. van Wely, S. Repping, F. van der Veen, P. M

Ovarian response to 150 µg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study Tamara Lerman, Marion Depenbusch,

High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation Jacob Farhi, Avi Ben.

Amir Wiser, Einat Shalom-Paz, Jordana H

HDlive ultrasound images in assisted reproduction treatment

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Establishment and validation of a score to predict ovarian response to stimulation in IVF Clelia Chalumeau, Jessika Moreau, Nicolas Gatimel, Clementine.

Anti-Müllerian hormone as a predictor of pregnancy following IVF

Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.

Sherman Silber Reproductive BioMedicine Online

Why are reproductive cancers more common in nulliparous women?

K. Gersak, A. Veble Reproductive BioMedicine Online

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

What’s on the mind of IVF consumers?

Sarah McCredie, William Ledger, Christos A. Venetis

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study A. Nasr Reproductive BioMedicine Online

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH) P. Barriere, T. Freour, D. Masson,

Removal of unilateral endometriomas is associated with immediate and sustained reduction in ovarian reserve Bulent Urman, Ebru Alper, Kayhan Yakin, Ozgur.

Reproductive BioMedicine Online

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.

Cross-border reproductive care: a review of the literature

Ovarian reserve in breast cancer: assessment with anti-Müllerian hormone Anne-Sophie Hamy, Raphaël Porcher, Caroline Cuvier, Sylvie Giacchetti, Marie-Hélène.

Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype C. Dechanet, C. Castelli,

Ronit Machtinger, Raoul Orvieto Reproductive BioMedicine Online

Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration Miro Šimun Alebić,

A retrospective analysis of ovarian stimulation with letrozole in women undergoing artificial insemination by donor X.J. Sun, L. Jiang, L.C. Ji, R. Nie,

Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,

A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment S.E. Elizur, W.Y. Son, H. Clarke, D. Morris,

V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss

The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF–ICSI Jianjun Zhou, Shanshan Wang, Bin Wang, Junxia.

Monozygotic triplet pregnancies after single blastocyst transfer: two cases and literature review Lionel Dessolle, Dalila Allaoua, Thomas Fréour, Claudine.

Stanley Paul Leibo (1937–2014): scientist, mentor and friend

Adverse pregnancy and neo-natal outcomes after assisted reproductive treatment in patients with pelvic endometriosis: a case–control study Marianne Jacques,

Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management – meta-analyses Daniele Santi, Giorgia.

Should we be promoting embryo transfer at blastocyst stage?

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

Pietro Gambadauro, Ramesan Navaratnarajah

Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M

The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting Reproductive BioMedicine Online

A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L

Is parental consanguinity associated with reduced ovarian reserve?

Ovarian reserve screening before contraception?

Cryobanking of human ovarian tissue: do women still want their tissue stored beyond 5 years? Kirsten Tryde Macklon, Erik Ernst, Anders Nyboe Andersen,

The significance of the number of CGG repeats and autoantibodies in premature ovarian failure Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,

Claudio Manna, Loris Nanni, Alessandra Lumini, Sebastiana Pappalardo

A. Finn, L. Scott, Thomas O’Leary, D. Davies, J. Hill

Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D

M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein

Fertility in cancer patients after cryopreservation of one ovary

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Antonio La Marca, Martina Capuzzo Reproductive.

Presentation transcript:

Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson, Paul Barriere Reproductive BioMedicine Online Volume 20, Issue 6, Pages 857-860 (June 2010) DOI: 10.1016/j.rbmo.2010.03.006 Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Receiver operating characteristic (ROC) curves for anti-Müllerian hormone (AMH) and antral follicle count (AFC) for prediction of poor ovarian response in (A) non-smokers and (B) smokers. Area under the curve (AUC) was 0.692 for AMH and 0.665 for AFC in non-smokers and 0.538 for AMH and 0.612 for AFC in smokers. Reproductive BioMedicine Online 2010 20, 857-860DOI: (10.1016/j.rbmo.2010.03.006) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions